 STAMFORD, Conn., Nov. 02, 2022 GLOBE NEWSWIRE -- Cara Therapeutics, Inc. Nasdaq: CARA, a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced that members of its Executive Leadership Team will present at the following investor conferences: 